ETX-10829_Etex-AR2017_WEB_2018_DEF2 (2)
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
6.1<br />
Financial report<br />
Consolidated financial statements<br />
<strong>Etex</strong> Annual Report 2017<br />
Financial report<br />
Consolidated financial statements<br />
Impairment testing<br />
In December 2017, impairment reviews were performed for a certain number of cash-generating units where impairment indicators arose.<br />
The carrying value of capital employed has been compared with the recoverable amount of the cash-generating unit. This review did not<br />
result in any impairment, except those that have been commented in Note 4.<br />
The recoverable amount of the cash-generating units was based on its value in use. The value in use was determined by discounting the<br />
future cash flows generated from the continuing use of the unit and was based on the following key assumptions:<br />
- cash flows were projected based on actual operating results and the 3 year business plan (extended to 10 years when the<br />
financial projections of a long-term strategy development is available for the cash-generating unit),<br />
- cash flows for further periods were extrapolated using a constant growth rate in a range of 1 % to 5 % depending on the<br />
countries involved and their respective inflation rates (a range of 1 % to 3 % in 2016).,<br />
- cash flows are discounted using the weighted average cost of capital (WACC) in a range of 7.8 % to 13.8 % depending on the<br />
countries involved (a range of 7.3 % to 11.8 % in 2016).<br />
In connection with the impairment testing process, the future cash flows were subjected to stress tests that included changes in individual<br />
macroeconomics parameters as part of the sensitivity analysis. A change of 100 basis point in the spread between the WACC and the<br />
growth rate at perpetuity indicate a potential need for an impairment charge of € 8.0 million.<br />
8.2. Business combinations<br />
On 22 December 2017, <strong>Etex</strong> acquired the remaining 59% shares of the Spanish Pladur, a leading Spanish manufacturer of gypsum<br />
products with a strong brand reputation on its domestic market, for a total contribution of €112,239 thousand, of which €45,712 thousand<br />
in cash (plus acquisition cost for €1,140 thousands). The remainder is made up of the historical value of the company previously equity<br />
accounted €29,403 thousand (see Note 12) and the gain recognised on the transaction: the company was previously accounted for as<br />
equity accounted investee and the transaction generated a gain of €37,123 thousand (see Note 4). In 2017, Pladur did not contribute to<br />
any significant sales or REBITDA given the timing of the transaction completion; the pro-forma REBITDA contribution would they have<br />
been consolidated from the beginning of the year amounts to €8,895 thousand.<br />
In April 2016, <strong>Etex</strong> acquired two companies in the United Kingdom: John Brash & Co., an established supplier of timber roofing battens,<br />
for a price of €15,770 thousand, and EOS Façades, a major manufacturer and supplier of steel framing systems, for a price of €4,983<br />
thousand; they contributed for 2016 to €33,450 and €5,960 thousand respectively in sales and to €2,504 and €765 thousand respectively<br />
in EBITDA.<br />
The fair value of the identifiable assets and liabilities of the businesses acquired in 2016 and in 2017 as at the date of acquisition are<br />
disclosed in the following table.<br />
In thousands of EUR Brash EOS 2016 Pladur 2017<br />
Note 8 – Goodwill and business combinations<br />
8.1. Reconciliation of the carrying amount of goodwill<br />
In thousands of EUR 2016 2017<br />
Gross book value 247,322 255,214<br />
Accumulated impairment losses -52,700 -52,043<br />
Net book value at the beginning of the year 194,622 203,171<br />
Additions through business combinations 5,903 2,113<br />
Translation differences 2,646 -2,309<br />
Net book value at the end of the year 203,171 202,975<br />
Gross book value 255,214 255,330<br />
Accumulated impairment losses -52,043 -52,355<br />
The main components of the carrying amount of goodwill are the following:<br />
In thousands of EUR 2016 2017<br />
Roofing 81,655 83,685<br />
Building Performance 87,502 85,289<br />
Industry 25,332 25,332<br />
<strong>Etex</strong> Nordic 8,552 8,539<br />
Others 130 130<br />
Total 203,171 202,975<br />
Non-current assets 8,599 514 9,113 149,456 149,456<br />
Property, plant and equipment 3,282 514 3,797 113,485 113,485<br />
Assets held for sale - - - 691 691<br />
Intangible assets 5,317 - 5,317 32,111 32,111<br />
Other non-current assets - - - 27 27<br />
Deferred tax assets - - - 3,143 3,143<br />
Current assets 16,730 3,051 19,781 30,210 30,210<br />
Inventories 5,447 323 5,770 8,902 8,902<br />
Trade and other receivables 10,960 2,217 13,177 19,196 19,196<br />
Current financial assets - - - 962 962<br />
Cash and cash equivalents 323 511 834 1,151 1,151<br />
TOTAL ASSETS 25,329 3,565 28,895 179,667 179,667<br />
Non-current liabilities 3,524 54 3,578 27,274 27,274<br />
Provisions 317 - 317 6,498 6,498<br />
Loans and borrowings 2,202 - 2,202 12,949 12,949<br />
Deferred tax liabilities 1,005 54 1,059 7,827 7,827<br />
Current liabilities 8,519 1,946 10,464 42,266 42,266<br />
Current portion of loans and borrowings - - - 15,421 15,421<br />
Trade and other liabilities 8,519 1,946 10,464 26,845 26,845<br />
TOTAL LIABILITIES 12,043 2,000 14,043 69,540 69,540<br />
Net identifiable assets and liabilities 13,287 1,565 14,852 110,126 110,126<br />
Group share 13,286 1,565 14,851 110,126 110,126<br />
Non-controlling interests - - 1 - -<br />
Acquisition price satisfied in cash (Group share) 15,770 4,983 20,752 112,239 112,239<br />
Goodwill generated 2,484 3,418 5,901 2,113 2,113<br />
<strong>Etex</strong> Annual Report 2017 p. 29<br />
<strong>Etex</strong> Annual Report 2017 p. 30<br />
124 125